Ads
related to: deletion 18q syndrome prognosis stage 0 lung cancer treatment stage 4
Search results
Results from the WOW.Com Content Network
Specialty. Medical genetics. Distal 18q- is a genetic condition caused by a deletion of genetic material within one of the two copies of chromosome 18. [1] The deletion involves the distal section of 18q and typically extends to the tip of the long arm of chromosome 18. [2]
Proximal 18q-is a rare genetic condition caused by a deletion of genetic material within one of the two copies of chromosome 18. This deletion involves the proximal (near the centromere ) section of the long arm of chromosome 18 somewhere between 18q11.2 (18.9 Mb) to 18q21.1 (43.8 Mb). [1]
Limited-stage small cell lung carcinoma. persistent cough, chest pains, rust-coloured sputum, shortness of breath, fatigue, weight loss, wheezing, hoarseness, pneumonia, bronchitis. median overall survival time of approximately 12–16 months, with five-year survival rate of approximately 26% and the long-term survival rate of approximately 4 - 5%.
Lung cancer staging is the assessment of the extent to which a lung cancer has spread from its original source. As with most cancers, staging is an important determinant of treatment and prognosis. In general, more advanced stages of cancer are less amenable to treatment and have a worse prognosis. The initial evaluation of non-small cell lung ...
18p-. 18p-, also known as monosomy 18p, deletion 18p syndrome, del (18p) syndrome, partial monosomy 18p, or de Grouchy syndrome 1, is a genetic condition caused by a deletion of all or part of the short arm (the p arm) of chromosome 18. It occurs in about 1 of every 50,000 births. [ 1 ]
Rare. Undifferentiated pleomorphic sarcoma ( UPS ), also termed pleomorphic myofibrosarcoma, [ 1] high-grade myofibroblastic sarcoma, and high-grade myofibrosarcoma, [ 2] is characterized by the World Health Organization (WHO) as a rare, poorly differentiated neoplasm (i.e., an abnormal growth of cells that have an unclear identity and/or cell ...
Oncology. Non-small-cell lung cancer ( NSCLC ), or non-small-cell lung carcinoma, is any type of epithelial lung cancer other than small-cell lung cancer (SCLC). NSCLC accounts for about 85% of all lung cancers. [ 1][ 2][ 3] As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small-cell carcinoma.
A walrus calf seemingly left behind by her herd near Alaska’s northernmost city is alert and “sassy” as she receives care at a nonprofit wildlife response center hundreds of miles away ...
Ads
related to: deletion 18q syndrome prognosis stage 0 lung cancer treatment stage 4